This study aims to develop an integrated model that combines radiomics, deep learning features, and clinical and ultrasound characteristics for predicting BRAF V600E mutations in patients with papillary thyroid carcinoma (PTC) combined with Hashimoto’s thyroiditis (HT). This evidence concerns the gene BRAF and hematocrit.